TMBIM4 and hepatocellular carcinoma: Together with the above findings, suggesting that NRF2 and S1R have similar patterns in maintaining the redox balance, both proteins are up‐regulated in HCC cells treated with sorafenib, and either inhibition of NRF2 or S1R accelerates ferroptosis, in which they regulate each other.